DCT
1:22-cv-01395
Novartis Pharma Corporation v. MSN Pharma Inc.
General
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (08/12/24)
Patent Owner
Operating Company (L)
PACER
1:22-cv-01395
Nature of Suit835 ANDA
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
10/25/22 - 07/11/25 | 36% |
Plaintiff
Attorney
Name | Ratings |
|---|---|
L5 A | |
L5 A | |
L5 B | |
-- -- -- | |
L5 A | |
L3 B | |
L5 A | |
L3 C | |
L2 D | |
L1 B | |
L1 B | |
L1 B | |
L1 B | |
L1 C | |
L1 C | |
L1 C | |
-- -- -- | |
-- -- -- |
No Attorneys
Defendant
Party
Name | Ratings |
|---|---|
L4 E | |
L5 A | |
L5 A | |
L5 A | |
L4 E | |
L4 E | |
L3 C | |
L3 C | |
L1 D | |
L1 E | |
-- -- -- |
No Parties
Attorney
Name | Ratings |
|---|---|
L5 A | |
L5 A | |
L5 A | |
L4 B | |
L4 E | |
L2 A | |
-- -- -- | |
-- -- -- | |
L4 E | |
L4 E | |
L3 C | |
L4 B | |
L4 D | |
L3 B | |
L3 C | |
L3 C | |
L2 E | |
L3 E | |
L4 E | |
L3 E | |
L1 B | |
L3 E | |
L4 E | |
-- -- -- | |
L3 E | |
L5 E | |
L1 E | |
L5 E | |
L3 E | |
L1 D |
No Attorneys